Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,740 | 1,311 | 97.6% |
| Education | $288.15 | 7 | 1.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $191.87 | 11 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $1,740 | 180 | $0 (2024) |
| ABBVIE INC. | $1,086 | 80 | $0 (2024) |
| SK Life Science, Inc. | $996.11 | 62 | $0 (2024) |
| UCB, Inc. | $965.56 | 86 | $0 (2024) |
| Boston Scientific Corporation | $836.02 | 31 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $782.83 | 57 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $738.43 | 58 | $0 (2022) |
| Abbott Laboratories | $728.95 | 25 | $0 (2024) |
| Allergan, Inc. | $727.89 | 56 | $0 (2022) |
| PFIZER INC. | $717.47 | 59 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,128 | 176 | Boston Scientific Corporation ($297.46) |
| 2023 | $2,482 | 150 | ABBVIE INC. ($325.73) |
| 2022 | $2,490 | 139 | SK Life Science, Inc. ($334.25) |
| 2021 | $1,996 | 145 | AbbVie Inc. ($241.68) |
| 2020 | $2,025 | 140 | Teva Pharmaceuticals USA, Inc. ($262.82) |
| 2019 | $3,140 | 209 | Teva Pharmaceuticals USA, Inc. ($402.22) |
| 2018 | $2,701 | 209 | Teva Pharmaceuticals USA, Inc. ($553.97) |
| 2017 | $2,258 | 161 | UCB, Inc. ($231.91) |
All Payment Transactions
1,329 individual payment records from CMS Open Payments — Page 1 of 54
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $22.79 | General |
| 12/17/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $166.05 | General |
| Category: General - DBS_NMD | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: PAIN | ||||||
| 12/12/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/11/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $30.64 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $3.82 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.77 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: PAIN | ||||||
| 12/05/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $5.78 | General |
| Category: Neuroscience | ||||||
| 12/05/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $1.39 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Neurology | ||||||
| 12/03/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $39.38 | General |
| Category: Neurology | ||||||
| 12/02/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Neuroscience | ||||||
| 12/02/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $5.02 | General |
| 12/02/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $1.19 | General |
| 11/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Neuropsychiatry | ||||||
| 11/20/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Rare Disease | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: PAIN | ||||||
| 11/18/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.28 | General |
| Category: NEUROLOGY | ||||||
| 11/18/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $3.32 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $32.47 | General |
| 11/14/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Neuromodulation | ||||||
| 11/13/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Neurology | ||||||
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.93 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 907 | 2,126 | $230,319 | $155,746 |
| 2022 | 10 | 858 | 2,094 | $225,785 | $157,535 |
| 2021 | 9 | 933 | 2,357 | $253,909 | $184,388 |
| 2020 | 11 | 958 | 2,080 | $230,397 | $157,203 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 57 | 58 | $11,635 | $9,116 | 78.3% |
| 95913 | Nerve transmission studies, 13 or more studies | Office | 2021 | 25 | 26 | $8,230 | $6,558 | 79.7% |
| 20553 | Injections of trigger points in 3 or more muscles | Office | 2021 | 28 | 64 | $4,263 | $3,251 | 76.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 28 | 769 | $1,889 | $780.62 | 41.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 395 | 905 | $103,995 | $69,042 | 66.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 156 | 156 | $33,902 | $22,853 | 67.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 107 | 171 | $26,479 | $18,191 | 68.7% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Office | 2020 | 57 | 61 | $23,245 | $16,764 | 72.1% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 92 | 160 | $17,108 | $11,995 | 70.1% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2020 | 58 | 58 | $11,954 | $8,746 | 73.2% |
| 95913 | Nerve transmission studies, 13 or more studies | Office | 2020 | 24 | 24 | $7,702 | $5,535 | 71.9% |
| 20553 | Injections of trigger points in 3 or more muscles | Office | 2020 | 21 | 40 | $2,727 | $1,879 | 68.9% |
| 95908 | Nerve transmission studies, 3-4 studies | Office | 2020 | 14 | 14 | $1,838 | $1,336 | 72.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 21 | 460 | $825.84 | $517.11 | 62.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 13 | 31 | $620.00 | $344.47 | 55.6% |
About Dr. Sevak Ohanian, MD
Dr. Sevak Ohanian, MD is a Neurology healthcare provider based in Katy, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922180637.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sevak Ohanian, MD has received a total of $20,220 in payments from pharmaceutical and medical device companies, with $3,128 received in 2024. These payments were reported across 1,329 transactions from 78 companies. The most common payment nature is "Food and Beverage" ($19,740).
As a Medicare-enrolled provider, Ohanian has provided services to 3,656 Medicare beneficiaries, totaling 8,657 services with total Medicare billing of $654,871. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Clinical Neurophysiology
- Location Katy, TX
- Active Since 10/20/2006
- Last Updated 02/10/2016
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1922180637
Products in Payments
- NURTEC ODT (Drug) $939.62
- APTIOM (Drug) $751.52
- RYTARY (Drug) $713.33
- BOTOX (Biological) $546.03
- Aimovig (Biological) $505.68
- AJOVY (Drug) $490.88
- INFINITY (Device) $489.71
- Xadago (Drug) $469.13
- QULIPTA (Drug) $431.52
- Vercise (Device) $408.03
- AJOVY (Biological) $404.66
- Neupro (Drug) $399.19
- UBRELVY (Drug) $399.14
- NUPLAZID (Drug) $397.68
- EMGALITY (Drug) $355.31
- AUBAGIO (Drug) $329.02
- NUEDEXTA (Drug) $325.06
- TECFIDERA (Drug) $324.35
- Briviact (Drug) $302.63
- AIMOVIG (Biological) $274.63
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Katy
Dr. Jose Diaz, M.d, M.D
Neurology — Payments: $105,577
Dr. Ankit Patel, M.d, M.D
Neurology — Payments: $21,121
Dr. Sadia Yasser, M.d, M.D
Neurology — Payments: $5,365
Shima Bozorgui, Md, Mph, MD, MPH
Neurology — Payments: $155.34
Ibrahim Noorbhai
Neurology — Payments: $40.16
Hannah Sutherland, Pt, Dpt, PT, DPT
Neurology